VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was up 16.7% on Wednesday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 143,956 shares traded hands during mid-day trading, an increase of 29% from the average daily volume of 111,732 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Trading Up 16.7 %
The company has a debt-to-equity ratio of 217.41, a quick ratio of 6.67 and a current ratio of 0.28. The stock has a market cap of C$16.50 million, a P/E ratio of -3.00 and a beta of 0.39. The stock has a 50-day moving average price of C$0.13 and a 200-day moving average price of C$0.17.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- Quiet Period Expirations Explained
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Best Aerospace Stocks Investing
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Evaluate a Stock Before Buying
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
